Moneycontrol PRO
Loans
Loans
HomeNewsBusinessStocksKilitch Drugs up 20% after Ethiopia allots land for pharma unit

Kilitch Drugs up 20% after Ethiopia allots land for pharma unit

Kilitch Drugs (India) shares were locked at 20 percent upper circuit at Rs 40.60 on Monday after Ethiopia government allotted land to its subsidiary for setting up pharma unit.

September 26, 2016 / 15:33 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More
    Moneycontrol Bureau

    Kilitch Drugs (India) shares were locked at 20 percent upper circuit at Rs 40.60 on Monday after Ethiopia government allotted land to its subsidiary for setting up pharma unit.

    "...announces allotment of land admeasuring 4317.5 square meters located in Oromia special zone by the Bureau of Rural Land and Environmental Protection, Federal Democratic Republic of Ethiopia to Kilitch Estro Biotech Plc," the Maharashtra-based healthcare company in its filing.

    The government has allotted land on a lease for a period of 45 years."This will also help to strengthen the presence of Kilitch in East Africa as Ethiopia is the third most populous nation in African continent after Nigeria and Egypt," the company said.

    At 15:16 hours IST, there were pending buy orders of 44,939 shares, with no sellers available on the Bombay Stock Exchange.Posted by Sunil Shankar Matkar

    first published: Sep 26, 2016 03:28 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347